{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Trumenba+Vaccine", "query": { "intervention": "Trumenba Vaccine" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 24, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Trumenba+Vaccine&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-11T02:29:29.280Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04084769", "title": "Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningococcal Immunisation (Healthy Volunteers)" ], "interventions": [ { "name": "Meningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid Conjugate vaccine MenACYW Conjugate vaccine", "type": "BIOLOGICAL" }, { "name": "Meningococcal Group B vaccine (Trumenba®)", "type": "BIOLOGICAL" }, { "name": "Meningococcal group B vaccine (Bexsero®)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "13 Years", "maximum_age": "26 Years", "sex": "ALL", "summary": "13 Years to 26 Years" }, "enrollment_count": 570, "start_date": "2019-09-03", "completion_date": "2020-09-14", "has_results": true, "last_update_posted_date": "2025-09-15", "last_synced_at": "2026-09-11T02:29:29.280Z", "location_count": 29, "location_summary": "Birmingham, Alabama • San Diego, California • Bardstown, Kentucky + 20 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Diego", "state": "California" }, { "city": "Bardstown", "state": "Kentucky" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Bridgeton", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT04084769" }, { "nct_id": "NCT02975596", "title": "MenB Vaccine: Implementation Via Information, Empowerment and Accessibility", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Meningococcal Vaccine" ], "interventions": [ { "name": "Awareness", "type": "OTHER" }, { "name": "Education", "type": "OTHER" }, { "name": "Empowerment", "type": "OTHER" }, { "name": "Accessibility", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "16 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "16 Years to 99 Years" }, "enrollment_count": 1326, "start_date": "2016-12", "completion_date": "2019-10-08", "has_results": false, "last_update_posted_date": "2020-02-06", "last_synced_at": "2026-09-11T02:29:29.280Z", "location_count": 6, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02975596" }, { "nct_id": "NCT05873751", "title": "A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States.", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Gonorrhea", "Chlamydia", "Meningococcal Vaccines" ], "interventions": [ { "name": "Trumenba Vaccine", "type": "BIOLOGICAL" }, { "name": "MenACWY Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "15 Years to 30 Years" }, "enrollment_count": 1307378, "start_date": "2023-04-24", "completion_date": "2024-03-31", "has_results": true, "last_update_posted_date": "2025-04-17", "last_synced_at": "2026-09-11T02:29:29.280Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05873751" }, { "nct_id": "NCT06128733", "title": "Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Meningococcal Immunisation", "Healthy Volunteers" ], "interventions": [ { "name": "Pentavalent Meningococcal ABCYW vaccine", "type": "BIOLOGICAL" }, { "name": "MenACYW conjugate vaccine", "type": "BIOLOGICAL" }, { "name": "Meningococcal group B vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "MenABCYW conjugate vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "10 Years to 25 Years" }, "enrollment_count": 1215, "start_date": "2023-10-31", "completion_date": "2025-08-27", "has_results": false, "last_update_posted_date": "2026-01-13", "last_synced_at": "2026-09-11T02:29:29.280Z", "location_count": 46, "location_summary": "Birmingham, Alabama • Guntersville, Alabama • Tempe, Arizona + 36 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Guntersville", "state": "Alabama" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Harrisburg", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06128733" }, { "nct_id": "NCT04440163", "title": "MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningococcal Vaccine" ], "interventions": [ { "name": "MenABCWY", "type": "BIOLOGICAL" }, { "name": "Saline", "type": "BIOLOGICAL" }, { "name": "Trumenba", "type": "BIOLOGICAL" }, { "name": "MenACWY-CRM", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "10 Years to 25 Years" }, "enrollment_count": 2431, "start_date": "2020-06-17", "completion_date": "2022-07-24", "has_results": true, "last_update_posted_date": "2023-04-18", "last_synced_at": "2026-09-11T02:29:29.280Z", "location_count": 61, "location_summary": "Birmingham, Alabama • Tempe, Arizona • Banning, California + 49 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Banning", "state": "California" }, { "city": "Madera", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04440163" }, { "nct_id": "NCT07197762", "title": "MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Neisseria Meningitidis" ], "interventions": [ { "name": "Trumenba", "type": "BIOLOGICAL" }, { "name": "PENBRAYA", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "18 Years to 25 Years" }, "enrollment_count": 125, "start_date": "2025-11-04", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2025-12-22", "last_synced_at": "2026-09-11T02:29:29.280Z", "location_count": 2, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07197762" }, { "nct_id": "NCT04350138", "title": "Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gonococcal Infection" ], "interventions": [ { "name": "Meningococcal Group B Vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 2606, "start_date": "2020-12-29", "completion_date": "2026-07-08", "has_results": false, "last_update_posted_date": "2026-07-24", "last_synced_at": "2026-09-11T02:29:29.280Z", "location_count": 10, "location_summary": "Birmingham, Alabama • Los Angeles, California • San Francisco, California + 6 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04350138" }, { "nct_id": "NCT02569632", "title": "Investigating the Immunogenicity of a U.S.-Licensed Meningococcal Serogroup B Vaccine (Trumenba)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Meningococcal Infections" ], "interventions": [ { "name": "Trumenba Vaccine (Wyeth/Pfizer Pharmaceuticals)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "UCSF Benioff Children's Hospital Oakland", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 18, "start_date": "2015-01", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2021-02-02", "last_synced_at": "2026-09-11T02:29:29.280Z", "location_count": 2, "location_summary": "Oakland, California • Worcester, Massachusetts", "locations": [ { "city": "Oakland", "state": "California" }, { "city": "Worcester", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02569632" }, { "nct_id": "NCT04318548", "title": "Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Infections, Meningococcal" ], "interventions": [ { "name": "Meningococcal Group B Vaccine (GSK3536829A) (rMenB+OMV NZ)", "type": "COMBINATION_PRODUCT" }, { "name": "Meningococcal MenACWY Conjugate Vaccine (GSK3536820A) (MenA lyo + MenCWY liquid)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT", "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "16 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "16 Years to 18 Years" }, "enrollment_count": 945, "start_date": "2020-08-25", "completion_date": "2023-11-21", "has_results": true, "last_update_posted_date": "2025-03-04", "last_synced_at": "2026-09-11T02:29:29.280Z", "location_count": 49, "location_summary": "Phoenix, Arizona • Bell Gardens, California • Los Angeles, California + 35 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Bell Gardens", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "Roseville", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04318548" }, { "nct_id": "NCT00297817", "title": "Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy Adolescents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Meningococcal Disease" ], "interventions": [ { "name": "serogroup B meningococcal vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novartis Vaccines", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "11 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "11 Years to 18 Years" }, "enrollment_count": 203, "start_date": "2006-02", "completion_date": "2007-04", "has_results": false, "last_update_posted_date": "2016-12-01", "last_synced_at": "2026-09-11T02:29:29.280Z", "location_count": 8, "location_summary": "Encinitas, California • Atlanta, Georgia • St Louis, Missouri + 5 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Galveston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00297817" } ] }